Novel approaches to identify protective malaria vaccine candidates

Efforts to develop vaccines against malaria have been the focus of substantial research activities for decades. Several categories of candidate vaccines are currently being developed for protection against malaria, based on antigens corresponding to the pre-erythrocytic, blood-stage or sexual stages...

Full description

Bibliographic Details
Main Authors: Wan Ni eChia, Yun Shan eGoh, Laurent eRenia
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-11-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00586/full
id doaj-06277d1dde904d00a8949224fa46f9c0
record_format Article
spelling doaj-06277d1dde904d00a8949224fa46f9c02020-11-24T22:01:09ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2014-11-01510.3389/fmicb.2014.00586115907Novel approaches to identify protective malaria vaccine candidatesWan Ni eChia0Yun Shan eGoh1Laurent eRenia2Agency for Science, Research and TechnologyAgency for Science, Research and TechnologyAgency for Science, Research and TechnologyEfforts to develop vaccines against malaria have been the focus of substantial research activities for decades. Several categories of candidate vaccines are currently being developed for protection against malaria, based on antigens corresponding to the pre-erythrocytic, blood-stage or sexual stages of the parasite. Long lasting sterile protection from Plasmodium falciparum sporozoite challenge has been observed in human following vaccination with whole parasite formulations, clearly demonstrating that a protective immune response targeting predominantly the pre-erythrocytic stages can develop against malaria. However, most of vaccine candidates currently being investigated, which are mostly subunits vaccines, have not been able to induce substantial (>50%) protection thus far. This is due to the fact that the antigens responsible for protection against the different parasite stages are still yet to be known and relevant correlates of protection have remained elusive. For a vaccine to be developed in a timely manner, novel approaches are required. In this article, we review the novel approaches that have been developed to identify the antigens for the development of an effective malaria vaccine.http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00586/fullAntibodiesMalariaVaccineLibraryantigen
collection DOAJ
language English
format Article
sources DOAJ
author Wan Ni eChia
Yun Shan eGoh
Laurent eRenia
spellingShingle Wan Ni eChia
Yun Shan eGoh
Laurent eRenia
Novel approaches to identify protective malaria vaccine candidates
Frontiers in Microbiology
Antibodies
Malaria
Vaccine
Library
antigen
author_facet Wan Ni eChia
Yun Shan eGoh
Laurent eRenia
author_sort Wan Ni eChia
title Novel approaches to identify protective malaria vaccine candidates
title_short Novel approaches to identify protective malaria vaccine candidates
title_full Novel approaches to identify protective malaria vaccine candidates
title_fullStr Novel approaches to identify protective malaria vaccine candidates
title_full_unstemmed Novel approaches to identify protective malaria vaccine candidates
title_sort novel approaches to identify protective malaria vaccine candidates
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2014-11-01
description Efforts to develop vaccines against malaria have been the focus of substantial research activities for decades. Several categories of candidate vaccines are currently being developed for protection against malaria, based on antigens corresponding to the pre-erythrocytic, blood-stage or sexual stages of the parasite. Long lasting sterile protection from Plasmodium falciparum sporozoite challenge has been observed in human following vaccination with whole parasite formulations, clearly demonstrating that a protective immune response targeting predominantly the pre-erythrocytic stages can develop against malaria. However, most of vaccine candidates currently being investigated, which are mostly subunits vaccines, have not been able to induce substantial (>50%) protection thus far. This is due to the fact that the antigens responsible for protection against the different parasite stages are still yet to be known and relevant correlates of protection have remained elusive. For a vaccine to be developed in a timely manner, novel approaches are required. In this article, we review the novel approaches that have been developed to identify the antigens for the development of an effective malaria vaccine.
topic Antibodies
Malaria
Vaccine
Library
antigen
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00586/full
work_keys_str_mv AT wanniechia novelapproachestoidentifyprotectivemalariavaccinecandidates
AT yunshanegoh novelapproachestoidentifyprotectivemalariavaccinecandidates
AT laurenterenia novelapproachestoidentifyprotectivemalariavaccinecandidates
_version_ 1725841416964276224